- Home
- Healthcare Practice
- Clinical Practice Guidelines Program
- Antifungal Prophylaxis
Antifungal Prophylaxis
- 2020 CPG – Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients (open access at Journal of Clinical Oncology)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Related Articles
2024 POGO Symposium Speakers Share Insights from their Sessions
February 21, 2025
The 2024 POGO Multidisciplinary Symposium on Childhood Cancer headed to Niagara-on-the-Lake, where…
Bruce Power and supplier partners donate $100,000 to Pediatric Oncology Group of Ontario
January 21, 2025
Originally published on the Bruce Power website, September 25, 2024
Antibacterial ProphylaxisAntifungal ProphylaxisChemotherapy-Induced Nausea & VomitingAcute delayed Phase CINVAnticipatory CINVBreakthrough & Refractory CINVEmetogenicity ClassificationAcute & Delayed Phase CINVChronic Pain*Clostridium Difficile InfectionFatigueFertility Preservation*MucositisOtotoxicityFever and NeutropeniaPlatelet Transfusion*Venous Thromboembolism*
Care Pathways


YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.